Pharmahungary Group and Remembrane developed and validated a medium throughput in vitro screening platform for testing potential cardiocytoprotective drug candidates against ischemia/reperfusion injury in the presence of hypercholesterolemia/metabolic disease comorbidities.
Further information here
Date: September 29-October 2, 2015
Helyszín: Milano, Italy
The international event in life sciences to boost your business, partnering and networking opportunities
Application deadline: September 11, 2015